Related Experiment Videos

Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci

S Handwerger1, D C Perlman, D Altarac

  • 1Department of Medicine, Beth Israel Medical Center, Mount Sinai School of Medicine, New York, New York 10003.

Insights

This study highlights emerging multidrug-resistant enterococci, including strains resistant to vancomycin and penicillin. These resistant enterococci (Enterococcus) present significant challenges for treating hospital-acquired infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Enterococci are significant causes of hospital-acquired infections.
  • Increasing antibiotic resistance in enterococci necessitates understanding novel resistance mechanisms.

Observation:

  • Three clinical enterococcal isolates from New York City hospitals exhibited co-resistance to vancomycin (VanA and VanB phenotypes) and high-level penicillin resistance.
  • Two Enterococcus faecium strains showed intrinsic penicillin resistance and low penicillin-binding protein 5 affinity.
  • One Enterococcus faecalis isolate produced beta-lactamase.

Findings:

  • Unlike other vancomycin-resistant enterococci, these strains did not show increased susceptibility to beta-lactams after vancomycin induction.
  • Penicillin and vancomycin combinations were not synergistic against these isolates.
  • Two strains demonstrated high-level resistance to all aminoglycosides.

Implications:

  • The emergence of enterococci with resistance to multiple antibiotic classes, including vancomycin and penicillin, severely limits treatment options.
  • These findings underscore the urgent need for surveillance and development of new therapeutic strategies against multidrug-resistant enterococci.

Related Concept Videos